Your browser doesn't support javascript.
loading
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
Cook, Lucy B; O'Dell, Gillian; Vourvou, Eleni; Palanicawandar, Renuka; Marks, Sasha; Milojkovic, Dragana; Apperley, Jane F; Loaiza, Sandra; Claudiani, Simone; Bua, Marco; Hockings, Catherine; Macdonald, Donald; Chaidos, Aris; Pavlu, Jiri; Cooper, Nichola; Fidler, Sarah; Randell, Paul; Innes, Andrew J.
Afiliación
  • Cook LB; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • O'Dell G; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Vourvou E; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Palanicawandar R; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Marks S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Milojkovic D; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Apperley JF; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Loaiza S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Claudiani S; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Bua M; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Hockings C; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Macdonald D; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Chaidos A; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Pavlu J; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Cooper N; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Fidler S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Randell P; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Innes AJ; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
Nat Commun ; 13(1): 6922, 2022 11 14.
Article en En | MEDLINE | ID: mdl-36376307
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Neoplasias Hematológicas / COVID-19 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Neoplasias Hematológicas / COVID-19 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido